Sovuna (Hydroxychloroquine Sulfate) Patent Expiration, LOE Window & CMS Spending

Sovuna (Hydroxychloroquine Sulfate) by Novitium: Off-Patent Genericized (AB Competition), 13 AB generics, $25K 2024 CMS Part D & Medicaid spend, and $1,665 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorNovitium
FDA Application & PathwayN214581 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors13
2024 CMS Total Public Spend$25K
2024 Medicare Part D Spend$25K
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,665 intro WAC)